Vitamin E inhibits lipid peroxidation-induced adhesion molecule expression in endothelial cells and decreases soluble cell adhesion molecules in healthy subjects

Cardiovascular Research

Volumn 57, Issue 2, 2003, Pages 563-571

  Van Dam, Bastiaan ^a   Van Hinsbergh, Victor W M ^a,b   Stehouwer, Coen D A ^a   Versteilen, Amanda ^a   Dekker, Henk ^a   Buytenhek, Rien ^b   Princen, Hans M ^b   Schalkwijk, Casper G ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b TNO   (Netherlands)

Author keywords

Endothelial function; Free radicals; Lipid metabolism

Indexed keywords

ALPHA TOCOPHEROL; BIOCHEMICAL MARKER; C REACTIVE PROTEIN; CARBON 11; CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HYDROGEN PEROXIDE; INTERCELLULAR ADHESION MOLECULE 1; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; CELL ACTIVATION; CELL CULTURE; CELL PROTECTION; CONTROLLED STUDY; ENDOTHELIUM CELL; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPID PEROXIDATION; LIPID SOLUBILITY; MOLECULAR PROBE; NEWBORN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SOLUBILITY; UMBILICAL VEIN;

ALPHA-TOCOPHEROL; ANTIOXIDANTS; C-REACTIVE PROTEIN; CELL ADHESION MOLECULES; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; HUMANS; HYDROGEN PEROXIDE; LIPID PEROXIDATION; OXIDATIVE STRESS; SOLUBILITY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 12244298153     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(02)00699-5     Document Type: Article

References (51)

1. Sacks T., Moldow C.F., Craddock P.R., Bowers T.K., Jacob H.S. Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes an in vitro model of immune vascular damage. J Clin Invest. 61:1978;1161-1167.
2. Babior B.M. Oxidants from phagocytes: agents of defense and destruction. Blood. 64:1984;959-966.
3. Parthasarathy S., Santanam N., Ramachandran S., Meilhac O. Oxidants and antioxidants in atherogenesis. An appraisal. J Lipid Res. 40:1999;2143-2157.
4. Shappell S.B., Toman C., Anderson D.C., Taylor A.A., Entman M.L., Smith C.W. Mac-1 (CD11b/CD18) mediates adherence-dependent hydrogen peroxide production by human and canine neutrophils. J Immunol. 144:1990;2702-2711.
5. Rahman A., Kefer J., Bando M., Niles W.D., Malik A.B. E-selectin expression in human endothelial cells by TNF-alpha-induced oxidant generation and NF-kappaB activation. Am J Physiol. 275:1998;L533-L544.
6. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 362:1993;801-809.
7. Ross R. Atherosclerosis: an inflammatory disease. New Engl J Med. 340:1999;115-126.
8. Schmidt K.N., Amstad P., Cerutti P., Baeuerle P.A. The roles of hydrogen peroxide and superoxide as messengers in the activation of transcription factor NF-kappa B. Chem Biol. 2:1995;13-22.
9. Schreck R., Albermann K., Baeuerle P.A. Nuclear factor kappa B: an oxidative stress-responsive transcription factor of eukaryotic cells. Free Radic Res Commun. 17:1992;221-237.
10. Marui N., Offermann M.K., Swerlick R., et al. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J Clin Invest. 92:1993;1866-1874.
11. Weber C., Erl W., Pietsch A., Strobel M., Ziegler-Heitbrock H.W., Weber P.C. Antioxidants inhibit monocyte adhesion by suppressing nuclear factor-kappa B mobilization and induction of vascular cell adhesion molecule-1 in endothelial cells stimulated to generate radicals. Arterioscler Thromb. 14:1994;1665-1673.
12. Roebuck K.A., Carpenter L.R., Lakshminarayanan V., Page S.M., Moy J.N., Thomas L.L. Stimulus-specific regulation of chemokine expression involves differential activation of the redox-responsive transcription factors AP-1 and NF-kappaB. J Leukoc Biol. 65:1999;291-298.
13. 2 and TNF-alpha and its effects on ICAM-1 expression in endothelial cells. Am J Physiol Lung. 279:2000;L302-L311.
14. 2 and tumor necrosis factor-alpha induce differential binding of the redox-responsive transcription factors AP-1 and NF-kappaB to the interleukin-8 promoter in endothelial and epithelial cells. J Biol Chem. 273:1998;32670-32678.
15. 2 and tumor necrosis factor-alpha activate intercellular adhesion molecule 1 (ICAM-1) gene transcription through distinct cis-regulatory elements within the ICAM-1 promoter. J Biol Chem. 270:1995;18966-18974.
16. Gey K.F., Puska P. Plasma vitamins E and A inversely correlated to mortality from ischemic heart disease in cross-cultural epidemiology. Ann NY Acad Sci. 570:1989;268-282.
17. Stampfer M.J., Hennekens C.H., Manson J.E., Colditz G.A., Rosner B., Willett W.C. Vitamin E consumption and the risk of coronary disease in women. New Engl J Med. 328:1993;1444-1449.
18. Rimm E.B., Stampfer M.J., Ascherio A., Giovannucci E., Colditz G.A., Willett W.C. Vitamin E consumption and the risk of coronary heart disease in men. New Engl J Med. 328:1993;1450-1456.
19. Losonczy K.G., Harris T.B., Havlik R.J. Vitamin E and vitamin C supplement use and risk of all-cause and coronary heart disease mortality in older persons: the Established Populations for Epidemiologic Studies of the Elderly. Am J Clin Nutr. 64:1996;190-196.
20. Devaraj S., Jialal I. Low-density lipoprotein postsecretory modification, monocyte function, and circulating adhesion molecules in type 2 diabetic patients with and without macrovascular complications. the effect of alpha-tocopherol supplementation. Circulation. 102:2000;191-196.
21. Princen H.M., Van Duyvenvoorde W., Buytenhek R., et al. Supplementation with low doses of vitamin E protects LDL from lipid peroxidation in men and women. Arterioscler Thromb Vasc Biol. 15:1995;325-333.
22. Upritchard J.E., Sutherland W.H., Mann J.I. Effect of supplementation with tomato juice, vitamin E, and vitamin C on LDL oxidation and products of inflammatory activity in type 2 diabetes. Diabetes Care. 23:2000;733-738.
23. Keaney J.F.J., Guo Y., Cunningham D., Shwaery G.T., Xu A., Vita J.A. Vascular incorporation of alpha-tocopherol prevents endothelial dysfunction due to oxidized LDL by inhibiting protein kinase C stimulation. J Clin Invest. 98:1996;386-394.
24. Kleinveld H.A., Hak-Lemmers H.L., Hectors M.P., De Fouw N.J., Demacker P.N., Stalenhoef A.F. Vitamin E and fatty acid intervention does not attenuate the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits. Arterioscl Thromb Vasc Biol. 15:1995;290-297.
25. Keaney J.F.J., Gaziano J.M., Xu A., et al. Low-dose alpha-tocopherol improves and high-dose alpha-tocopherol worsens endothelial vasodilator function in cholesterol-fed rabbits. J Clin Invest. 93:1994;844-851.
26. Skyrme-Jones R.A., Meredith I.T. Soluble adhesion molecules, endothelial function and vitamin E in type 1 diabetes. Coron Artery Dis. 12:2001;69-75.
27. Faruqi R., De la Motte C., DiCorleto P.E. Alpha-tocopherol inhibits agonist-induced monocytic cell adhesion to cultured human endothelial cells. J Clin Invest. 94:1994;592-600.
28. Pap E.H., Drummen G.P., Winter V.J., et al. Ratio-fluorescence microscopy of lipid oxidation in living cells using C11-BODIPY(581/591). FEBS Lett. 453:1999;278-282.
29. Van Hinsbergh V.W., Bertina R.M., Van Wijngaarden A., van T.N., Emeis J.J., Haverkate F. Activated protein C decreases plasminogen activator-inhibitor activity in endothelial cell-conditioned medium. Blood. 65:1985;444-451.
30. Carlos T.M., Schwartz B.R., Kovach N.L., et al. Vascular cell adhesion molecule-1 mediates lymphocyte adherence to cytokine-activated cultured human endothelial cells. Blood. 76:1990;965-970.
31. Schalkwijk C.G., Poland D.C., Van Dijk W., et al. Plasma concentration of C-reactive protein is increased in type I diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: evidence for chronic inflammation. Diabetologia. 42:1999;351-357.
32. Pieper G.M., Gross G.J. Oxygen free radicals abolish endothelium-dependent relaxation in diabetic rat aorta. Am J Physiol. 255:1988;H825-H833.
33. Tsao P.S., Niebauer J., Buitrago R., et al. Interaction of diabetes and hypertension on determinants of endothelial adhesiveness. Arterioscler Thromb Vasc Biol. 18:1998;947-953.
34. Kubes P., Arfors K.E., Granger D.N. Platelet-activating factor-induced mucosal dysfunction. role of oxidants and granulocytes. Am J Physiol. 260:1991;G965-G971.
35. Granger D.N. Role of xanthine oxidase and granulocytes in ischemia-reperfusion injury. Am J Physiol. 255:1988;H1269-H1275.
36. Chan A.C., Tran K. The uptake of (R,R,R)alpha-tocopherol by human endothelial cells in culture. Lipids. 25:1990;17-21.
37. Shimpuku H., Tachi Y., Shinohara M., Ohura K. Effect of vitamin E on the degradation of hydrogen peroxide in cultured human umbilical vein endothelial cells. Life Sci. 68:2000;353-359.
38. Grisham M.B., Gaginella T.S., Von Ritter C., Tamai H., Be R.M., Granger D.N. Effects of neutrophil-derived oxidants on intestinal permeability, electrolyte transport, and epithelial cell viability. Inflammation. 14:1990;531-542.
39. Johnston B., Kanwar S., Kubes P. Hydrogen peroxide induces leukocyte rolling: modulation by endogenous antioxidant mechanisms including NO. Am J Physiol. 271:1996;H614-H621.
40. Erl W., Weber C., Wardemann C., Weber P.C. alpha-Tocopheryl succinate inhibits monocytic cell adhesion to endothelial cells by suppressing NF-kappa B mobilization. Am J Physiol. 273:1997;H634-H640.
41. Neuschwander-Tetri B.A., Roll F.J. Glutathione measurement by high-performance liquid chromatography separation and fluorometric detection of the glutathione-orthophthalaldehyde adduct. Anal Biochem. 179:1989;236-241.
42. 2 and tumor necrosis factor-alpha activate intercellular adhesion molecule 1 (ICAM-1) gene transcription through distinct cis-regulatory elements within the ICAM-1 promoter. J Biol Chem. 270:1995;18966-18974.
43. Stephens N.G., Parsons A., Schofield P.M., Kelly F., Cheeseman K., Mitchinson M.J. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet. 347:1996;781-786.
44. Yusuf S., Dagenais G., Pogue J., Bosch J., Sleight P. Vitamin E supplementation and cardiovascular events in high-risk patients: The Heart Outcomes Prevention Evaluation Study Investigators. New Engl J Med. 342:2000;154-160.
45. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet. 354:1999;447-455.
46. Lawson J.A., Rokach J., FitzGerald G.A. Isoprostanes: formation, analysis and use as indices of lipid peroxidation in vivo. J Biol Chem. 274:1999;24441-24444.
47. Princen H.M., Van Poppel G., Vogelezang C., Buytenhek R., Kok F.J. Supplementation with vitamin E but not beta-carotene in vivo protects low density lipoprotein from lipid peroxidation in vitro. Effect of cigarette smoking. Arterioscler Thromb Vasc Biol. 12:1992;554-562.
48. Jialal I., Fuller C.J., Huet B.A. The effect of alpha-tocopherol supplementation on LDL oxidation. A dose-response study. Arterioscler Thromb Vasc Biol. 15:1995;190-198.
49. Davi G., Ciabattoni G., Consoli A., et al. In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. Circulation. 99:1999;224-229.
50. Marangon K., Devaraj S., Tirosh O., Packer L., Jialal I. Comparison of the effect of alpha-lipoic acid and alpha-tocopherol supplementation on measures of oxidative stress. Free Radic Biol Med. 27:1999;1114-1121.
51. Meagher E.A., Barry O.P., Lawson J.A., Rokach J., FitzGerald G.A. Effects of vitamin E on lipid peroxidation in healthy persons. J Am Med Assoc. 285:2001;1178-1182.